CLBS
:NASDAQ

Add to watchlist
$0.7751
Last updated:01/19/2022
CLBS: NASDAQ
$0.7751
Caladrius Biosciences Inc

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced…

Dividend yield
-
P/E ratio
-
vs. 0.00x forward
Payout ratio
-
CASH payout ratio
-
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
Based on missed expected dividend payments we detected that dividend payouts might be suspended. Check the company website for further information.
CLBS dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company value
Market capitalization
Nano (49.04M)